Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1464579

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1464579

PTA Peripheral DCB Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

PUBLISHED:
PAGES: 106 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4000
PDF (Site License)
USD 8000
PDF (Global License)
USD 12000

Add to Cart

GlobalData's Medical Devices sector report, "PTA Peripheral DCB Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the PTA Peripheral DCB Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A PTA Peripheral DCB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis, or restenosis of the peripheral arteries. PTA Peripheral DCB catheters provide fast, short-term, homogenous, local drug delivery to the vessel wall, while preserving the anatomy of the vessel, promoting enhanced vessel healing, and reducing the need for prolonged dual antiplatelet therapy. They can be used to treat native and in-stent restenosis (ISR), bifurcations, small vessels, and long lesions.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the PTA Peripheral DCB Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of PTA Peripheral DCB Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of PTA Peripheral DCB Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Product Code: GDME1723EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 PTA Peripheral DCB Catheters Overview

3 Products under Development

  • 3.1 PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development
  • 3.2 PTA Peripheral DCB Catheters - Pipeline Products by Territory
  • 3.3 PTA Peripheral DCB Catheters - Pipeline Products by Regulatory Path
  • 3.4 PTA Peripheral DCB Catheters - Pipeline Products by Estimated Approval Date
  • 3.5 PTA Peripheral DCB Catheters - Ongoing Clinical Trials

4 PTA Peripheral DCB Catheters - Pipeline Products under Development by Companies

  • 4.1 PTA Peripheral DCB Catheters Companies - Pipeline Products by Stage of Development
  • 4.2 PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development

5 PTA Peripheral DCB Catheters Companies and Product Overview

  • 5.1 Acotec Scientific Co Ltd Company Overview
    • 5.1.1 Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 AnGes Inc Company Overview
    • 5.2.1 AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 AngioCure, Inc. Company Overview
    • 5.3.1 AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Ascenion GmbH Company Overview
    • 5.4.1 Ascenion GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Becton Dickinson and Co Company Overview
    • 5.5.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Boston Scientific Corp Company Overview
    • 5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Cardionovum GmbH Company Overview
    • 5.7.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Chansu Vascular Technologies LLC Company Overview
    • 5.8.1 Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Concept Medical Inc Company Overview
    • 5.9.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Contego Medical LLC Company Overview
    • 5.10.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Cordis US Corp Company Overview
    • 5.11.1 Cordis US Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Dingke Medical Technology (Suzhou) Co Ltd Company Overview
    • 5.12.1 Dingke Medical Technology (Suzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 eucatech AG Company Overview
    • 5.13.1 eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
    • 5.14.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Lutonix Inc Company Overview
    • 5.15.1 Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Medtronic Plc Company Overview
    • 5.16.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Micell Technologies Inc Company Overview
    • 5.17.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 OrbusNeich Company Overview
    • 5.18.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 Orchestra BioMed Inc Company Overview
    • 5.19.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 Pulsus Medical LLC (Inactive) Company Overview
    • 5.20.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 QualiMed Innovative Medizinprodukte GmbH Company Overview
    • 5.21.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 Shanghai Easy-Flow Medical Tech Co Ltd Company Overview
    • 5.22.1 Shanghai Easy-Flow Medical Tech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
    • 5.23.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 SiL Vascular Ltd Company Overview
    • 5.24.1 SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 Spectranetics Corp Company Overview
    • 5.25.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 Stemplant LLC Company Overview
    • 5.26.1 Stemplant LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 SurModics Inc Company Overview
    • 5.27.1 SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 Tailored Medical Devices Inc Company Overview
    • 5.28.1 Tailored Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 TransMed7 LLC Company Overview
    • 5.29.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 Vascular Nanotransfer Technologies Company Overview
    • 5.30.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 Zhejiang Batai Medical Technology Co Ltd Company Overview
    • 5.31.1 Zhejiang Batai Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
    • 5.32.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 PTA Peripheral DCB Catheters- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Product Code: GDME1723EPD

List of Tables

  • PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development
  • PTA Peripheral DCB Catheters - Pipeline Products by Territory
  • PTA Peripheral DCB Catheters - Pipeline Products by Regulatory Path
  • PTA Peripheral DCB Catheters - Pipeline Products by Estimated Approval Date
  • PTA Peripheral DCB Catheters - Ongoing Clinical Trials
  • PTA Peripheral DCB Catheters Companies - Pipeline Products by Stage of Development
  • PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development
  • Glossary

List of Figures

  • PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development
  • PTA Peripheral DCB Catheters - Pipeline Products by Territory
  • PTA Peripheral DCB Catheters - Pipeline Products by Regulatory Path
  • PTA Peripheral DCB Catheters - Pipeline Products by Estimated Approval Date
  • PTA Peripheral DCB Catheters - Ongoing Clinical Trials
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!